Literature DB >> 9144384

Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor.

S Hiscox1, W G Jiang.   

Abstract

Cancer metastasis involves the passage of tumour cells into and out of blood or lymphatic circulatory systems and requires their interaction with the endothelial cells lining these vessels. Hepatocyte growth factor/scatter factor (HGF/SF) is a multifunctional protein that enhances tumour cell motility and extracellular matrix invasion and has been implicated as a mediator of metastasis. In this study, we have investigated the effect of HGF/SF on tumour cell-endothelial cell interactions. A fluorescent tumour cell-endothelial cell attachment assay demonstrated that, following endothelial monolayer stimulation with HGF/SF, tumour cell attachment to endothelium is increased. Addition of anti-CD44 antibodies in this assay inhibited the effects of HGF/SF. Western blotting studies showed that HGF/SF increased expression of the adhesion molecule CD44 in endothelial cells. These results were confirmed by both immunohistochemical staining and a cell-surface adhesion molecule ELISA. These results suggest that HGF/SF plays a key role in the initial adhesion mechanism between tumour cells and endothelial cells via up-regulation of CD44.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144384     DOI: 10.1006/bbrc.1997.6388

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Scatter factor influences the formation of prostate epithelial cell colonies on bone marrow stroma in vitro.

Authors:  S H Lang; N W Clarke; N J George; N G Testa
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

2.  Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.

Authors:  W Wick; C Grimmel; C Wild-Bode; M Platten; M Arpin; M Weller
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

Review 3.  Grb2 signaling in cell motility and cancer.

Authors:  Alessio Giubellino; Terrence R Burke; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2008-08       Impact factor: 6.902

4.  Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol.

Authors:  H Ren; T Boulikas; K Lundstrom; A Söling; P C Warnke; N G Rainov
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

Review 5.  Breast cancer stem cells and their role in resistance to endocrine therapy.

Authors:  Ciara S O'Brien; Gillian Farnie; Sacha J Howell; Robert B Clarke
Journal:  Horm Cancer       Date:  2011-04       Impact factor: 3.869

6.  Glycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptake.

Authors:  Surya P Lamichhane; Neha Arya; Nirdesh Ojha; Esther Kohler; V Prasad Shastri
Journal:  Int J Nanomedicine       Date:  2015-01-19

Review 7.  Resistance to endocrine therapy: are breast cancer stem cells the culprits?

Authors:  Ciara S O'Brien; Sacha J Howell; Gillian Farnie; Robert B Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-02-28       Impact factor: 2.673

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.